Tocqueville Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Tocqueville Asset Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-60,000	Closed	-$376K	–	1023
2015 Q1	$376K	Buy	60,000 +10,000	+20%	+$57.7K	﹤0.01%	770
2014 Q4	$315K	Buy	+50,000	New	+$305K	﹤0.01%	801
2014 Q3	–	Sell	-175	Closed	-$1K	–	1424
2014 Q2	$1K	Sell	175 -79,025	-100%	-$890K	﹤0.01%	1710
2014 Q1	$1.89M	Sell	79,200 -37,300	-32%	-$541K	0.02%	385
2013 Q4	$1.24M	Buy	116,500 +29,800	+34%	+$329K	0.02%	424
2013 Q3	$1.16M	Buy	86,700 +11,825	+16%	+$187K	0.01%	495
2013 Q2	$983K	Buy	+74,875	New	+$1.01M	0.01%	505

Other funds holding ECYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tocqueville Asset Management's ECYT Position: Q2 2015 in Review

Tocqueville Asset Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2015, closing a stake of 60,000 shares — an estimated $376K sold.

Tocqueville Asset Management first reported a position in ECYT in Q2 2013 and held it in 7 quarters. The position peaked at $1.89M in Q1 2014. 98 funds tracked by Wall St. Rank hold ECYT as of Q2 2015.

Tocqueville Asset Management reported no remaining Endocyte, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Tocqueville Asset Management sold 60,000 Endocyte, Inc. Common Stock shares in Q2 2015, an estimated $376K.
Tocqueville Asset Management first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
Tocqueville Asset Management's Endocyte, Inc. Common Stock position peaked at $1.89M in Q1 2014.
98 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2015.

Based on Tocqueville Asset Management's 13F filing for Q2 2015, filed 31 Jul 2015.